deltatrials
Not Yet Recruiting PHASE3 INTERVENTIONAL 2-arm NCT00610051

ALP-1 Continuous Intravenous Infusion to Maintain Clinical Stability in Advanced Heart Failure

Phase 3 Study of Alprostadil Continuous Intravenous Infusion to Maintain Clinical Stability in Severe Heart Failure Patients

Sponsor: Biopeutics Co., Ltd

Conditions End Stage Cardiac Failure HFrEF - Heart Failure With Reduced Ejection Fraction NYHF Class III-IV
Interventions Alprostadil
Updated 13 times since 2017 Last updated: Dec 12, 2025 Started: Oct 31, 2026 Primary completion: Nov 30, 2029 Completion: Dec 31, 2030
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on End Stage Cardiac Failure and HFrEF - Heart Failure With Reduced Ejection Fraction, this trial is actively recruiting participants. The trial is conducted by Biopeutics Co., Ltd and has accumulated 13 data snapshots since 2026. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshot~Jun 2018 – ~Aug 2019 · 14 months · monthly snapshot~Aug 2019 – ~Jan 2021 · 17 months · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Oct 2021 · 8 months · monthly snapshot~Oct 2021 – ~Jul 2022 · 9 months · monthly snapshot~Jul 2022 – ~Dec 2022 · 5 months · monthly snapshot~Dec 2022 – ~Jun 2023 · 6 months · monthly snapshot~Jun 2023 – ~Jul 2024 · 13 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Jan 2026 · 16 months · monthly snapshot~Jan 2026 – present · 7 months · monthly snapshot

Change History

13 versions recorded

  1. Jan 2026 — Present [monthly]

    Not Yet Recruiting PHASE3

  2. Sep 2024 — Jan 2026 [monthly]

    Not Yet Recruiting PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Not Yet Recruiting PHASE3

  4. Jun 2023 — Jul 2024 [monthly]

    Not Yet Recruiting PHASE3

  5. Dec 2022 — Jun 2023 [monthly]

    Not Yet Recruiting PHASE3

▶ Show 8 earlier versions

  1. Jul 2022 — Dec 2022 [monthly]

    Not Yet Recruiting PHASE3

  2. Oct 2021 — Jul 2022 [monthly]

    Not Yet Recruiting PHASE3

  3. Feb 2021 — Oct 2021 [monthly]

    Not Yet Recruiting PHASE3

    Status: Suspended → Not Yet Recruiting

  4. Jan 2021 — Feb 2021 [monthly]

    Suspended PHASE3

  5. Aug 2019 — Jan 2021 [monthly]

    Suspended PHASE3

  6. Jun 2018 — Aug 2019 [monthly]

    Suspended PHASE3

  7. Feb 2017 — Jun 2018 [monthly]

    Suspended PHASE3

  8. Jan 2017 — Feb 2017 [monthly]

    Suspended PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Biopeutics Co., Ltd
Data source: Biopeutics Co., Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations